Table 1.
Symptoms of the COVID-19 convalescents during 1 year and 2 years follow-ups.
| Item | 1 year | 2 years | P-valuea |
|---|---|---|---|
| n = 76 | n = 80 | ||
| Post-discharge discomfort,bn (%) | 46 (60.5) | 38 (47.5) | 0.103 |
| Fatigue | 25 (33.9) | 15 (18.8) | 0.043c |
| Muscle weakness | 19 (25.0) | 7 (8.8) | 0.007c |
| Hair loss | 17 (22.4) | 7 (8.8) | 0.019c |
| Sleep difficulties | 14 (18.4) | 17 (21.3) | 0.658 |
| Hypertension | 12 (15.8) | 10 (12.5) | 0.555 |
| Decreased appetite | 3 (3.9) | 4 (5.0) | 1.000 |
| Taste disorder | 1 (1.3) | 3 (3.8) | 0.621 |
| Smell disorder | 1 (1.3) | 6 (7.5) | 0.117 |
| mMRC score,dn (%) | |||
| 0 | 45 (59.2) | 60 (75.0) | 0.036c |
| 1 | 27 (35.5) | 15 (18.8) | 0.018c |
| 2 | 3 (3.9) | 5 (6.3) | 0.720 |
| 3 | 1 (1.3) | 0 | 0.487 |
| 4 | 0 | 0 | Not applicable |
| Pain, n (%) | 19 (25.0) | 10 (12.5) | 0.045c |
| Joint pain | 7 (9.2) | 2 (2.5) | 0.092 |
| Myalgia | 6 (7.9) | 2 (2.5) | 0.159 |
| Chest pain | 5 (6.6) | 1 (1.3) | 0.110 |
| Headache | 2 (2.6) | 6 (7.5) | 0.278 |
| Circulatory symptoms, n (%) | 22 (28.9) | 11 (13.8) | 0.020c |
| Feeling cold | 17 (22.4) | 3 (3.8) | 0.001c |
| Excessive sweating when mild exercise/rest/sleep | 11 (14.5) | 7 (8.8) | 0.263 |
| Palpitations | 6 (7.9) | 0 | 0.012c |
| Arrhythmia | 2 (2.6) | 3 (3.8) | 1.000 |
| Respiratory symptoms, n (%) | 16 (21.1) | 24 (30.0) | 0.201 |
| Chest distress | 10 (13.2) | 6 (7.5) | 0.244 |
| Shortness of breath | 6 (7.9) | 7 (8.8) | 0.847 |
| Cough | 4 (5.3) | 8 (10.0) | 0.267 |
| Sore throat or foreign body sensation | 4 (5.3) | 2 (2.5) | 0.434 |
| Sensitive to dust | 0 | 1 (1.3) | 1.000 |
| Gastrointestinal symptoms, n (%) | 9 (11.8) | 2 (2.5) | 0.023c |
| Hematochezia | 3 (3.9) | 0 | 0.113 |
| Constipation | 3 (3.9) | 1 (1.3) | 0.358 |
| Nausea | 2 (2.6) | 1 (1.3) | 0.613 |
| Hemolymphatic symptoms, n (%) | 7 (9.2) | 0 | 0.006c |
| Gum bleeding | 6 (7.9) | 0 | 0.012c |
| Jaundice | 2 (2.6) | 0 | 0.236 |
| Urinary symptoms, n (%) | 6 (7.9) | 3 (3.8) | 0.319 |
| Copious urine | 3 (4.0) | 1 (1.3) | 0.358 |
| Dysuria | 1 (1.3) | 1 (1.3) | 1.000 |
| Urinary calculi | 1 (1.3) | 0 | 0.487 |
| Limb edema | 1 (1.3) | 0 | 0.487 |
| Proteinuria | 0 | 1(1.3) | 1.000 |
| Comorbidities, n (%) | 23 (30.3) | 16 (20.0) | 0.139 |
| Hypertension | 10 (13.2) | 8 (10.0) | 0.537 |
| Diabetes | 5 (6.6) | 4 (5.0) | 0.741 |
| Chronic gastric disease | 3 (3.9) | 2 (2.5) | 0.676 |
| Chronic pharyngitis | 3 (3.9) | 1 (1.3) | 0.358 |
| Chronic liver disease | 2 (2.6) | 2 (2.5) | 1.000 |
| Cardia-cerebrovascular diseases | 2 (2.6) | 2 (2.5) | 1.000 |
| Lung cancer | 2 (2.6) | 2 (2.5) | 1.000 |
a
P value of Chi-square/Fisher's exact test between 1 year and 2 years.
b
Overall proportion of convalescents who reported at least one discomfort after discharge.
c
There are significant differences between the two time points (α = 0.05).
d
mMRC score: modified British Medical Research Council score. Percentages may not add up to exactly 100% due to rounding. The higher the score (range 0–4), the more severe the dyspnea.